Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPM1B | O75688 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13846233 | 0.80 | CES2 (0.41) | CES2 | |
| SCHEMBL20995893 | 0.80 | PPM1B (0.52) | PPM1BPTPN1PPP1CCCYP2C19CHRNB2 | |
| SCHEMBL5362897 | 0.79 | CES2 (0.44) | PPM1BPTPN1PPP1CCCES2 | |
| SCHEMBL9551372 | 0.78 | CHRM2 (0.43) | CYP2C19CHRNB2CHRNA4CHRM2CHRM4 | |
| SCHEMBL3281202 | 0.76 | CHRM2 (0.40) | CYP2C19CHRNB2CHRNA4CHRM2CHRM4 | |
| SCHEMBL24483227 | 0.75 | CYP2C19 (0.37) | PPM1BPTPN1PPP1CCCYP2C19CHRNB2 | |
| SCHEMBL14087182 | 0.73 | — | — | |
| SCHEMBL20405610 | 0.73 | — | — | |
| SCHEMBL17892815 | 0.73 | — | — | |
| SCHEMBL5521657 | 0.73 | CHRM2 (0.43) | PPM1BPTPN1PPP1CCCYP2C19CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10548867-B2 | Soothing composition for animals, comprising at least one fatty acid and nepetalactone | VIRBAC (FR) | 2020-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10548867-B2 | Soothing composition for animals, comprising at least one fatty acid and nepetalactone | CAT, ELOVL1, ELOVL6 | PPM1B 1866/4885PTPN1 1522/4885PPP1CC 3145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.